High expression of heme oxygenase-1 in target organs may attenuate acute graft-versus-host disease through regulation of immune balance of TH17/Treg
- 1 July 2016
- journal article
- Published by Elsevier in Transplant Immunology
- Vol. 37, 10-17
Abstract
No abstract availableKeywords
Funding Information
- National Science Foundation of China (81070444)
- International Cooperation Project of Guizhou Province (2012-7043)
This publication has 42 references indexed in Scilit:
- A Novel Differential Predict Model Based on Matrix-Assisted Laser Ionization Time-of-Flight Mass Spectrometry and Serum Ferritin for Acute Graft-versus-Host DiseaseBioMed Research International, 2013
- Advances in predicting acute GVHDBritish Journal of Haematology, 2012
- Hematopoietic Stem Cell TransplantationA Global PerspectiveJAMA, 2010
- Graft-versus-host diseaseThe Lancet, 2009
- Cell and gene therapy using mesenchymal stem cells (MSCs)Journal of Autoimmunity, 2008
- In vivo bioimaging using photogenic rats: Fate of injected bone marrow-derived mesenchymal stromal cellsJournal of Autoimmunity, 2008
- Mesenchymal Stem Cells in Cancer: Tumor-Associated Fibroblasts and Cell-Based Delivery VehiclesInternational Journal of Hematology, 2007
- Update on the management of acute graft-versus-host diseaseCurrent Opinion in Oncology, 2006
- Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expressionBlood, 2005
- Haematopoietic cell transplantation as immunotherapyNature, 2001